NEW YORK (GenomeWeb) – NanoString Technologies said today that it has entered new commercial partnerships with five contract research organizations aimed at expanding access to its Digital Spatial Profiling (DSP) technology.

The agreements — with Covance, Cancer Genetics, Core Diagnostics, Propath UK, and another undisclosed company — will allow the CROS to market DSP services to their customers through a technology access program in advance of NanoString's expected commercial launch of the DSP instrument platform in 2019.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.